SCHEMBL584990

SCHEMBL584990

O=C(OCc1ccccc1)c1cn(C2CC2)c2c3c(c(F)cc2c1=O)N1C[C@](O)(COc2ccc(N4C[C@H](CO)OC4=O)cc2F)C[C@H]1CO3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALML3 P27482 2/20 0.34
STAT3 P40763 1/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 2/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
GSK3B P49841 1/20 0.32
HDAC3 O15379 3/20 0.32
TUBB4A P04350 3/20 0.32
TUBB P07437 3/20 0.32
TUBA3C P0DPH7 3/20 0.32
HDAC4 P56524 3/20 0.32
TUBA1B P68363 3/20 0.32
TUBA4A P68366 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2531151 1.00 CALML3 (0.34) CALML3STAT3ALDH1A1KDM4EPOLB
SCHEMBL585304 0.95 ALDH1A1 (0.33) CALML3STAT3ALDH1A1KDM4EPOLB
SCHEMBL585303 0.95 ALDH1A1 (0.33) CALML3STAT3ALDH1A1KDM4EPOLB
SCHEMBL585451 0.95 ALDH1A1 (0.33) CALML3STAT3ALDH1A1KDM4EPOLB
SCHEMBL2526650 0.93 STAT3 (0.33) STAT3ALDH1A1KDM4EPOLBLMNA
SCHEMBL2844562 0.92 TOP2B (0.35) STAT3ALDH1A1KDM4EPOLBLMNA
SCHEMBL2841950 0.92 TOP2B (0.35) STAT3ALDH1A1KDM4EPOLBLMNA
SCHEMBL3063470 0.92 TOP2B (0.35) STAT3ALDH1A1KDM4EPOLBLMNA
SCHEMBL583933 0.92 KCNH2 (0.39) ALDH1A1KDM4EPOLBTDP1CHRM2
SCHEMBL583932 0.92 KCNH2 (0.39) ALDH1A1KDM4EPOLBTDP1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102217-B1 4- (2-OXO-OXAZOLIDIN-3YL)-PHENOXYMETHYLE DERIVATIVEAS AS ANTIBACTERIALS ACTELION PHARMACEUTICALS LTD (CH) 2012-02-15 EP disclosed
US-8039466-B2 5-hydroxymethyl-oxazolidin-2-one antibacterials ACTELION PHARMACEUTICAL LTD. (CH) 2011-10-18 US disclosed
US-20100069376-A1 5-HYDROXYMETHYL-OXAZOLIDIN-2-ONE ANTIBACTERIALS ACTELION PHARMACEUTICALS, LTD. (CH) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069376-A1 5-HYDROXYMETHYL-OXAZOLIDIN-2-ONE ANTIBACTERIALS OGFOD1, ODC1, OXGR1 CALML3 3115/4885STAT3 4566/4885ALDH1A1 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.